Cargando…
The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer
SIMPLE SUMMARY: Two-thirds of breast cancer patients present an estrogen receptor–positive tumor at diagnosis, and the main treatment options for these patients are endocrine therapies such as aromatase inhibitors, selective modulators of estrogen receptor activity or selective estrogen receptor dow...
Autores principales: | La Camera, Giusi, Gelsomino, Luca, Caruso, Amanda, Panza, Salvatore, Barone, Ines, Bonofiglio, Daniela, Andò, Sebastiano, Giordano, Cinzia, Catalano, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962645/ https://www.ncbi.nlm.nih.gov/pubmed/33800302 http://dx.doi.org/10.3390/cancers13051160 |
Ejemplares similares
-
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
por: Barone, Ines, et al.
Publicado: (2021) -
The Biology of Exosomes in Breast Cancer Progression: Dissemination, Immune Evasion and Metastatic Colonization
por: Giordano, Cinzia, et al.
Publicado: (2020) -
Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism
por: Gelsomino, Luca, et al.
Publicado: (2022) -
Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
por: Andò, Sebastiano, et al.
Publicado: (2019) -
Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells
por: Augimeri, Giuseppina, et al.
Publicado: (2020)